170 related articles for article (PubMed ID: 25099582)
1. PALB2 mutations and breast-cancer risk.
Evans MK; Longo DL
N Engl J Med; 2014 Aug; 371(6):566-8. PubMed ID: 25099582
[No Abstract] [Full Text] [Related]
2. Breast-cancer risk in families with mutations in PALB2.
Antoniou AC; Casadei S; Heikkinen T; Barrowdale D; Pylkäs K; Roberts J; Lee A; Subramanian D; De Leeneer K; Fostira F; Tomiak E; Neuhausen SL; Teo ZL; Khan S; Aittomäki K; Moilanen JS; Turnbull C; Seal S; Mannermaa A; Kallioniemi A; Lindeman GJ; Buys SS; Andrulis IL; Radice P; Tondini C; Manoukian S; Toland AE; Miron P; Weitzel JN; Domchek SM; Poppe B; Claes KB; Yannoukakos D; Concannon P; Bernstein JL; James PA; Easton DF; Goldgar DE; Hopper JL; Rahman N; Peterlongo P; Nevanlinna H; King MC; Couch FJ; Southey MC; Winqvist R; Foulkes WD; Tischkowitz M
N Engl J Med; 2014 Aug; 371(6):497-506. PubMed ID: 25099575
[TBL] [Abstract][Full Text] [Related]
3. Breast-cancer risk in families with mutations in PALB2.
Lee AS; Ang P
N Engl J Med; 2014 Oct; 371(17):1650-1. PubMed ID: 25337758
[No Abstract] [Full Text] [Related]
4. Breast-cancer risk in families with mutations in PALB2.
Sopik V; Narod SA
N Engl J Med; 2014 Oct; 371(17):1650. PubMed ID: 25337757
[No Abstract] [Full Text] [Related]
5. Breast-cancer risk in families with mutations in PALB2.
Antoniou AC; Foulkes WD; Tischkowitz M
N Engl J Med; 2014 Oct; 371(17):1651-2. PubMed ID: 25337756
[No Abstract] [Full Text] [Related]
6. Breast cancer: PALB2--a new player in hereditary breast cancer.
Errico A
Nat Rev Clin Oncol; 2014 Oct; 11(10):560. PubMed ID: 25135369
[No Abstract] [Full Text] [Related]
7. A PALB2 germline mutation associated with hereditary breast cancer in Italy.
Papi L; Putignano AL; Congregati C; Piaceri I; Zanna I; Sera F; Morrone D; Genuardi M; Palli D
Fam Cancer; 2010 Jun; 9(2):181-5. PubMed ID: 19763884
[TBL] [Abstract][Full Text] [Related]
8. Biallelic mutations in PALB2 cause Fanconi anemia subtype FA-N and predispose to childhood cancer.
Reid S; Schindler D; Hanenberg H; Barker K; Hanks S; Kalb R; Neveling K; Kelly P; Seal S; Freund M; Wurm M; Batish SD; Lach FP; Yetgin S; Neitzel H; Ariffin H; Tischkowitz M; Mathew CG; Auerbach AD; Rahman N
Nat Genet; 2007 Feb; 39(2):162-4. PubMed ID: 17200671
[TBL] [Abstract][Full Text] [Related]
9. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.
Rahman N; Seal S; Thompson D; Kelly P; Renwick A; Elliott A; Reid S; Spanova K; Barfoot R; Chagtai T; Jayatilake H; McGuffog L; Hanks S; Evans DG; Eccles D; ; Easton DF; Stratton MR
Nat Genet; 2007 Feb; 39(2):165-7. PubMed ID: 17200668
[TBL] [Abstract][Full Text] [Related]
10. Screening for BRCA1, BRCA2, CHEK2, PALB2, BRIP1, RAD50, and CDH1 mutations in high-risk Finnish BRCA1/2-founder mutation-negative breast and/or ovarian cancer individuals.
Kuusisto KM; Bebel A; Vihinen M; Schleutker J; Sallinen SL
Breast Cancer Res; 2011 Feb; 13(1):R20. PubMed ID: 21356067
[TBL] [Abstract][Full Text] [Related]
11. Novel germline PALB2 truncating mutations in African American breast cancer patients.
Zheng Y; Zhang J; Niu Q; Huo D; Olopade OI
Cancer; 2012 Mar; 118(5):1362-70. PubMed ID: 21932393
[TBL] [Abstract][Full Text] [Related]
12. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene.
Jones S; Hruban RH; Kamiyama M; Borges M; Zhang X; Parsons DW; Lin JC; Palmisano E; Brune K; Jaffee EM; Iacobuzio-Donahue CA; Maitra A; Parmigiani G; Kern SE; Velculescu VE; Kinzler KW; Vogelstein B; Eshleman JR; Goggins M; Klein AP
Science; 2009 Apr; 324(5924):217. PubMed ID: 19264984
[TBL] [Abstract][Full Text] [Related]
13. Contribution of the PALB2 c.2323C>T [p.Q775X] founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent.
Tischkowitz M; Sabbaghian N; Hamel N; Pouchet C; Foulkes WD; Mes-Masson AM; Provencher DM; Tonin PN
BMC Med Genet; 2013 Jan; 14():5. PubMed ID: 23302520
[TBL] [Abstract][Full Text] [Related]
14. PALB2 gene increases breast cancer risk.
Tanday S
Lancet Oncol; 2014 Sep; 15(10):e423. PubMed ID: 25328949
[No Abstract] [Full Text] [Related]
15. Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.
Catucci I; Milgrom R; Kushnir A; Laitman Y; Paluch-Shimon S; Volorio S; Ficarazzi F; Bernard L; Radice P; Friedman E; Peterlongo P
Fam Cancer; 2012 Sep; 11(3):483-91. PubMed ID: 22692731
[TBL] [Abstract][Full Text] [Related]
16. Tumour morphology predicts PALB2 germline mutation status.
Teo ZL; Provenzano E; Dite GS; Park DJ; Apicella C; Sawyer SD; James PA; Mitchell G; Trainer AH; Lindeman GJ; Shackleton K; Cicciarelli L; ; Buys SS; Andrulis IL; Mulligan AM; Glendon G; John EM; Terry MB; Daly M; Odefrey FA; Nguyen-Dumont T; Giles GG; Dowty JG; Winship I; Goldgar DE; Hopper JL; Southey MC
Br J Cancer; 2013 Jul; 109(1):154-63. PubMed ID: 23787919
[TBL] [Abstract][Full Text] [Related]
17. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
Blanco A; de la Hoya M; Osorio A; Diez O; Miramar MD; Infante M; Martinez-Bouzas C; Torres A; Lasa A; Llort G; Brunet J; Graña B; Perez Segura P; Garcia MJ; Gutiérrez-Enríquez S; Carracedo Á; Tejada MI; Velasco EA; Calvo MT; Balmaña J; Benitez J; Caldés T; Vega A
PLoS One; 2013; 8(7):e67538. PubMed ID: 23935836
[TBL] [Abstract][Full Text] [Related]
18. PALB2/FANCN: recombining cancer and Fanconi anemia.
Tischkowitz M; Xia B
Cancer Res; 2010 Oct; 70(19):7353-9. PubMed ID: 20858716
[TBL] [Abstract][Full Text] [Related]
19. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
[TBL] [Abstract][Full Text] [Related]
20. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
Casadei S; Norquist BM; Walsh T; Stray S; Mandell JB; Lee MK; Stamatoyannopoulos JA; King MC
Cancer Res; 2011 Mar; 71(6):2222-9. PubMed ID: 21285249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
